Crop Life Science Ltd IPO Timeline

Crop Life Science Ltd IPO opens on 18-Aug-2023, and closes on 22-Aug-2023. The Crop Life Science Ltd IPO bid date is from 18-Aug-2023 to 22-Aug-2023. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.

Event Date
Crop Life Science Ltd IPO Opening Date 18-Aug-2023
Crop Life Science Ltd IPO Closing Date 22-Aug-2023
Basis of Allotment 25-Aug-2023
Initiation of Refunds 28-Aug-2023
Credit of Shares to Demat 29-Aug-2023
Crop Life Science Ltd IPO Listing Date 30-Aug-2023

Crop Life Science Ltd IPO Lot Size

Crop Life Science Ltd IPO lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or 104000).

Application Lots Shares Amount
Minimum 1 2000 ₹104000
Maximum 1 2000 ₹104000

Crop Life Science Ltd IPO Details

Crop Life Science Ltd IPO Date 18-Aug-2023 to 22-Aug-2023
Crop Life Science Ltd IPO Face Value Shares of ₹10 per share
Crop Life Science Ltd IPO Price ₹52 per share
Crop Life Science Ltd IPO Lot Size 2000
Issue Size Shares of ₹10 (aggregating up to ₹26.73 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹26.73 Cr)
Offer for Sale -
Issue Type Fixed Price - SME
Listing At NSE - SME
QIB Shares Offered -
Retail Shares Offered -
NII (HNI) Shares Offered -
Company Promoters Rajesh Lunagariya, Ashvinkumar Lunagaria.

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • 1 Repayment of unsecured Loan
  • 2 Long Term Working Capital Requirement
  • 3 General Corporate Purposes

Company Financials

Crop Life Science Ltd Financial Information (Restated)

Period Ended Total Assets Total Revenue Profit After Tax
03-2023 101.59 132.03 4.07
03-2022 94.58 102.39 2.81
03-2021 86.30 119.50 3.70
Amount in ₹ Crore
  • Its Wide and variety range of products.
  • Extensive Distribution Network.
  • Experienced promoters, directors and managerial Team.
  • Prime Location of its factories.
  • Quality Assurance.
  • There are outstanding litigations by against the Company which if determined against it, could adversely impact financial conditions.
  • The Company has given loans/advances and corporate guarantees to group companies in which its Directors are interested and which is not in compliance with the provisions of Section 185/295 of the Companies Act, 2013/1956.
  • The company sales are to a large extent dependent on the overall area under cultivation and the cropping pattern adopted by the farming community in India. Any reduction in the area under cultivation and the cropping pattern may impact its revenues and profitability.
  • The Company has certain contingent liabilities which may adversely affect its financial position.
  • At present, one of the company promoter group company Hetban Spechem Limited has similar facilities for the manufacture of the products in which issuer company is engaged which may create a conflict of interest, Further, the company don't enjoy contractual protection by way of a non- compete or other agreement or arrangement with the group company.
  • The company factory, few offices and all the godowns are on Lease/rent basis.
  • The company business requires to obtain and renew certain registrations, licenses and permits from government and regulatory authorities and the failure to obtain and renew them in a timely manner may adversely affect its business operations.
  • Trade Receivables are the major part of Working capital requirement of the Company and as on November 30,2022 outstanding disputed trade receivables were of 418.83 lacs and out of them, the trade receivables outstanding for more than 2 years were 416.05 lacs.
  • The company business is subject to climatic conditions and is cyclical in nature. Seasonal variations and unfavourable local and global weather patterns may have an adverse effect on its business, results of operations and financial condition.
  • The company is yet to receive certain registrations in connection with the protection of its intellectual property rights relating to the company products. Such failure to protect its intellectual property rights could adversely affect the competitive position, business, financial condition and profitability.
  • There are no long-term supply agreements for the major raw materials with its vendors/suppliers. The company Business may be adversely affected if there is any disruption in the raw material supply or due to nonavailability of raw material.
  • The company is subject to product liability claims in relation to the quality and use of the products. This may harm its reputation and/or have an adverse impact on the company sales, revenue and profitability.
  • The company agrochemical business could be adversely affected by introduction of alternative crop protection measures such as biotechnology products, pest resistant seeds or genetically modified ("GM") crops.
  • A shortage or non-availability of electricity, fuel or water may adversely affect of the company manufacturing operations and have an adverse effect on its business, results of operations and financial condition.
  • Non-compliance with and changes in, safety, health and environmental laws and other applicable regulations, may adversely affect its business, results of operations and financial condition.
  • The company success is based on the efficient working of Testing Laboratory and Research & Development section.
  • The company Overseas customer's has to get the approval/registration of its products from their respective country before purchasing the same.
  • The Company is dependent on few of customers and suppliers for sales and purchase from top 10 customers and suppliers. Loss of any of these large customer and supplier will significantly affect its revenues and profitability.
  • The company Manufacturing Units are subject to inspection under the GPCB.
  • A slowdown or shutdown in its manufacturing operations or under-utilization of the company manufacturing facilities could have an adverse effect on its business, results of operations and financial condition.
  • The company do business with its customers on purchase order basis and do not have long term contracts with most of them.
  • Failure to manage its inventory could have an adverse effect on the company net sales, profitability, cash flow and liquidity.
  • The company face competition in its business from both domestic and international competitors. Such competition would have an adverse impact on the company business and financial performance.
  • The company profitability will remain highly volatile from quarter-to-quarter impacting volatility in the shares price.
  • The company international sales and operations are subject to many uncertainties and its are exposed to foreign currency exchange rate fluctuations.
  • Any failure of the company information technology systems could adversely affect its business and the operations.
  • The company could be harmed by employee misconduct or fraud that are difficult to detect and any such incidences could adversely affect its financial condition, results of operations and reputation.
  • Non-compliance with any of the rules and regulations and law of the land of the company clients' company may result in claims by way of damagesand could adversely affect its business and results of operations.
  • Trade policy of the company customer's country will have a vital impact on its business and profitability.
  • The company Promoters and promoter group will continue to retain majority control in the Company after the Issue, which will enable them to influence the outcome of matters submitted to shareholders for approval.
  • The company is highly depends on smooth supply and transportation and timely delivery of its products from the manufacturing facilities to the customers. Various uncertainties and delays or non-delivery of the company products will affect its sales.
  • The company may not be successful in implementing its business strategies.
  • The Company is subject to high working capital requirements and its inability to fund these requirements in a timely manner may adversely impact the company financial performance.
  • The company has entered into related party disclosures and may continue to do so in the future.
  • The company success depends heavily upon its individual Promoters and Senior Management for their continuing services, strategic guidance and financial support.
  • The company Promoters, Directors and Key Managerial Personnel may have interest in its Company, other than reimbursement of expenses incurred or remuneration.
  • The company future fund requirements, in the form of further issue of capital or securities and/or loans taken by it, may be prejudicial to the interest of the Shareholders depending upon the terms on which they are eventually raised.
  • The Company has entered into loan agreements with banks which contain restrictive covenants.
  • The company insurance coverage may not be adequate to protect it against certain operating hazards and this may have a material adverse effect on its business.
  • Changes in technology may render the company current technologies obsolete or require it to make substantial capital investments.
  • The company has not entered into any technical support service contract for the maintenance and smooth functioning of its equipment's and machineries, which may affect the company performance.
  • The company has unsecured loans from promoters and promoter group, which are repayable on demand. Any demand from lenders for repayment of such unsecured loans, may adversely affect its business operations.
  • In the event there is any delay in the completion of the Issue, there would be a corresponding delay in the completion of the objects of this Issue which would in turn affect its revenues and results of operations.
  • The company has not identified any alternate source of raising the funds required for its 'objects of the Issue'. Any shortfall in raising / meeting the same could adversely affect the company growth plans, operations and financial performance.
  • There is no monitoring agency appointed by the Company and the deployment of funds are at the discretion of the Management and the Board of Directors, though it shall be monitored by its Audit Committee.
  • The company ability to pay dividends in the future will depends upon future earnings, financial condition, cash flows, working capital requirements and capital expenditures.
  • The company has experienced negative cash flows in previous years / periods. Any operating losses or negative cash flow in the future could adversely affect its results of operations and financial condition.
  • The company has not independently verified certain data in this Draft Prospectus.
  • The requirements of being a listed company may strain its resources.
  • There is no guarantee that the Equity Shares issued pursuant to the Issue will be listed on the NSE-EMERGE Platform in a timely manner or at all.
  • There is no existing market for the Equity Shares, and the company do not know if one will develop to provide you with adequate liquidity. Further, an active trading market for the Equity Shares may not develop and the price of the Equity Shares may be volatile.
  • The price of the Equity Shares may be highly volatile after the Issue.
  • You will not be able to sell immediately on the Stock Exchanges any of the Equity Shares you purchase in the Issue.
  • There are restrictions on daily movements in the trading price of the Equity Shares, which may adversely affect a shareholder's ability to sell Equity Shares or the price at which Equity Shares can be sold at a particular point in time.
  • Sale of Equity Shares by the company Promoters or other significant shareholder(s) may adversely affect the trading price of the Equity Shares.
  • Rights of shareholders under Indian laws may be more limited than under the laws of other jurisdictions.
  • Increasing its Product Portfolio.
  • Increase in geographical presence.
  • Extensive Marketing Set up.
  • Strengthening up its business through effective branding and promotional activities.

Crop Life Science Ltd IPO Promoter Holding

Pre Issue Share Holding 70.02%
Post Issue Share Holding 49.03%

Crop Life Science Ltd IPO Subscription Status (Bidding Detail)

The Crop Life Science Ltd IPO is subscribed - times on Aug 22, 2023 05:00:00 PM. The public issue subscribed - times in the retail category, - times in the QIB category, and - times in the NII category. Check Day by Day Subscription Details (Live Status)

Category QIB NII Retail Employee Total
Subscription (times) - - - - -

Crop Life Science Ltd IPO Prospectus

Crop Life Science Ltd IPO Listing Date

Listing Date 30 Aug 23
BSE Script 79036
NSE Symbol CLSL
Listing In NSE - SME
ISIN INE00NH01017
IPO Price ₹52
Face Value ₹10

Crop Life Science Ltd IPO Registrar

Purva Sharegistry (India) Pvt

Phone: +91-022 2301 8261
Email: support@purvashare.com
Website: www.purvashare.com

Crop Life Science Ltd IPO Lead Manager(s)

  1. Interactive Financial Services Ltd

FAQs on Crop Life Science Ltd IPO

Crop Life Science Ltd IPO, which opens for subscription from 18-Aug-2023 to 22-Aug-2023 has an issue size of ₹26.73 crore. The issue type is book building issue.

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for Crop Life Science Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

Crop Life Science Ltd IPO Opens for subscription from 18-Aug-2023 to 22-Aug-2023.

The lot size of Crop Life Science Ltd is 2000 shares. Retail investors can subscribe to minimum 1 lot and maximum 1 lots. The minimum and maximum application value is ₹104000 and ₹104000 respectively.

Allotment date for Crop Life Science Ltd is 25-Aug-2023 and refund of application amount (in case allotment is not received) will begin from 28-Aug-2023. If your allotment goes through, then shares will be credited in your Demat account by 29-Aug-2023.

The registrar for Crop Life Science Ltd IPO is Purva Sharegistry (India) Pvt. You can check your IPO allotment status on the registrar's website.

The shares of Crop Life Science Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Power your investments with our smart trading platforms

mobilefooterimg
  • app_download_icon_img
    5 million+
    App downloads
  • 1_Click_icon_img
    1-Click
    Order Placement
  • higherreturns_icon_img
    2,361 Crore+
    Average Daily Turnover
Download App